Research examining the metabolic profile of SLE found increased oxidative activity, as well as lower levels of tyrosine and tryptophan, in SLE patients relative to controls, suggesting increased activity of aromatic amino acid decarboxylase. The results suggest metabolomics may have the ability to measure disease severity in SLE…
![](https://www.the-rheumatologist.org/wp-content/uploads/2016/07/anyaivanova_Shutterstock_GenericLabTech_500x270-150x150.jpg)